Search results
Author(s):
Jowana Lyn S Pagulayan-Rivas
,
Marc Louie Del Rosario
,
Ofelia Valencia
,
et al
Added:
1 month ago
Author(s):
Divaka Perera
Added:
1 month ago
ACC 2026 — Prof Divaka Perera (Guy's & St Thomas' Hospital and King's College London, UK) joins us to discuss findings from the CHIP-BCIS3 trial, examining the role of percutaneous left ventricular unloading in patients undergoing high-risk coronary intervention.This phase 3 randomised controlled trial enrolled 300 patients with severe left ventricular dysfunction and extensive coronary artery…
View more
ACURATE Neo2 in Rheumatic Aortic Stenosis
Author(s):
Ivan Wong
,
Michael Chiang
,
Angus Shing Fung Chui
,
et al
Added:
1 year ago
Case Report
Percutaneous Retrieval Dislodged Port Catheter
Author(s):
Dharmaraj Karthikesan
,
Mohd Ridzuan Mohd Said
,
Chin Yung Chea
,
et al
Added:
1 year ago
Case Report
APSC Position Statement on TAVI for Aortic Stenosis
Author(s):
Jonathan Yap
,
Kentaro Hayashida
,
Michael Kang-Yin Lee
,
et al
Added:
1 year ago
Consensus Statement
Author(s):
Devi Nair
,
Laurence Epstein
,
Robert D Schaller
Added:
7 months ago
In this essential episode of Rhythm Interventions Unplugged, host Dr Devi Nair (St. Bernard's Medical Center, US) sits down with two leading experts in cardiac device management: Dr Larry Epstein and Dr Robert Schaller. Together, they explore a critical challenge facing electrophysiologists today - managing pacemaker and ICD leads in patients requiring tricuspid valve interventions.Dr Epstein and…
View more
Author(s):
Nisa Nadhira Mohd Nazi
,
Raja Ezman Raja Shariff
,
Mohd Rahal Yusoff
,
et al
Added:
1 year ago
Author(s):
David J Cohen
Added:
6 months ago
TCT 2025 - The PREVUE-VALVE study finds an 8.2% prevalence of moderate or greater valvular heart disease amongst Americans age 65-85, increasing to 18.4% when participants with mild to moderate VHD were included.Dr David J. Cohen (Cardiovascular Research Foundation & St Francis Hospital, US) joins us to discuss findings from the PREVUE-VALVE study, examining age and sex-specific prevalence of…
View more
NY Valves 2025 Late-Breaking Science Collection
Video Series
Author(s):
Thomas Modine
Added:
11 months ago
EuroPCR25 - Findings from TRINITY trial show favourable outcomes with the LuX-Valve Plus TTVR system in high-risk patients with severe tricuspid regurgitation.We are joined by Prof Thomas Modine (CHU de Bordeaux, Bordeaux, FR) to discuss key findings from the TRINITY trial. This prospective, single-arm, multi-center study evaluated the LuX-Valve Plus transjugular tricuspid valve replacement…
View more